March 2023 — Limits of the regulatory evaluation of resorcinol as a thyroid disruptor: When limited experimental data challenge established effects in humans. Severe hypothyroidism has been reported in humans during resorcinol
therapeutic use. However, available data highlight… Environ Res vol. 222, , p. 115330
, ISSN
1096-0953